Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications.

Jeong, Michaela; Lee, Yeji; Park, Jeongeun; Jung, Hyein; Lee, Hyukjin

Jeong, Michaela; Lee, Yeji; Park, Jeongeun; Jung, Hyein; Lee, Hyukjin.

Afiliación

Jeong M; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, South Korea.
Lee Y; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, South Korea.
Park J; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, South Korea.
Jung H; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, South Korea.
Lee H; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, South Korea. Electronic address: hyukjin@ewha.ac.kr.

Adv Drug Deliv Rev ; 200: 114990, 2023 09.

Article en En | MEDLINE | ID: mdl-37423563

Asunto(s)

COVID-19; Nanopartículas; Humanos; ARN Interferente Pequeño/genética; Lípidos; Liposomas

Palabras clave

Extrahepatic delivery; RNA therapeutics; Repeated dose; lipid nanoparticles (LNPs)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nanopartículas / COVID-19 Límite: Humans Idioma: En Revista: Adv Drug Deliv Rev Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google